19
Publications
1.9K
Citations
17
H-Index
1990
Active since
Affiliations
Boehringer Ingelheim (United States)(Current)
Mark E. Labadia is an author at Boehringer Ingelheim (United States) specializing in medicine, immunology, and natural sciences.
Top concepts
MedicineImmunologyNatural SciencesCell BiologyPharmacologyBiochemistryInflammationCell SignalingChemical BiologyMedicinal Chemistry
Publications per year
1990–2021
19
19
Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor
Vincent J. Merluzzi, Karl D. Hargrave, Mark E. Labadia et al. · Science · 1990 · 745 citations
Steven S. Pullen, Mark E. Labadia, Richard H. Ingraham et al. · Biochemistry · 1999 · 148 citations
Discovery and Characterization of a Substrate Selective p38α Inhibitor
Walter Davidson, Lee Frego, Gregory W. Peet et al. · Biochemistry · 2004 · 110 citations
Epstein‐Barr virus‐induced gene 3 negatively regulates IL‐17, IL‐22 and RORγt
Jianfei Yang, Min Yang, Tin Min Htut et al. · European Journal of Immunology · 2008 · 97 citations · Full text
Inflammation, Cytokine, Allergy +15
Rows per page
1–5 of 19